RANKINGS
Lowest P/E — Healthcare
Price-to-Earnings ratio. Lower P/E may indicate undervaluation relative to earnings.
86 companies with P/E Ratio data.
Ranked by P/E Ratio(86)
| # | Ticker | Name | Market Cap | P/E Ratio |
|---|---|---|---|---|
| 1 | CHRS | $245M | 1.3 | |
| 2 | RIGL | $564M | 1.5 | |
| 3 | AGEN | $146M | 2.3 | |
| 4 | INVA | $1.6B | 3.1 | |
| 5 | BTMD | $61M | 3.9 | |
| 6 | ABEO | $329M | 5.0 | |
| 7 | CF | $17.3B | 8.1 | |
| 8 | OMER | $799M | 9.3 | |
| 9 | ACAD | $3.7B | 9.9 | |
| 10 | CYRX | $791M | 9.9 | |
| 11 | AMPH | $831M | 10.5 | |
| 12 | PLX | $170M | 11.1 | |
| 13 | ADMA | $1.8B | 11.2 | |
| 14 | SEE | $6.2B | 12.3 | |
| 15 | ZTS | $32.6B | 12.3 | |
| 16 | TGTX | $5.8B | 12.6 | |
| 17 | PAHC | $1.2B | 13.1 | |
| 18 | CLX | $10.9B | 14.4 | |
| 19 | ALTO | $422M | 14.4 | |
| 20 | COLL | $1.1B | 14.5 | |
| 21 | REGN | $64.5B | 14.6 | |
| 22 | MTX | $2.4B | 14.8 | |
| 23 | EXEL | $12.7B | 15.2 | |
| 24 | CBT | $4.5B | 15.9 | |
| 25 | PPG | $25.2B | 15.9 | |
| 26 | BMY | $116.8B | 16.1 | |
| 27 | REX | $1.5B | 16.2 | |
| 28 | NAGE | $307M | 16.5 | |
| 29 | SIGA | $336M | 16.6 | |
| 30 | LFVN | $99M | 17.3 | |
| 31 | NEU | $7.1B | 17.3 | |
| 32 | IPAR | $3.0B | 17.9 | |
| 33 | IOSP | $2.0B | 17.9 | |
| 34 | GILD | $166.9B | 18.1 | |
| 35 | UTHR | $23.6B | 18.4 | |
| 36 | NATR | $374M | 18.8 | |
| 37 | ANIP | $1.8B | 19.4 | |
| 38 | LXU | $902M | 19.6 | |
| 39 | PFE | $149.2B | 19.9 | |
| 40 | PG | $334.3B | 20.1 | |
| 41 | RPM | $13.5B | 20.3 | |
| 42 | KVUE | $33.2B | 20.5 | |
| 43 | AVNT | $3.2B | 20.6 | |
| 44 | BIIB | $28.9B | 21.1 | |
| 45 | EMN | $8.7B | 21.7 | |
| 46 | FUL | $3.5B | 21.9 | |
| 47 | HALO | $7.9B | 22.6 | |
| 48 | LNTH | $6.5B | 23.2 | |
| 49 | AMGN | $181.8B | 23.3 | |
| 50 | IFF | $19.4B | 23.4 | |
| 51 | ABT | $149.1B | 23.8 | |
| 52 | NBIX | $15.9B | 23.8 | |
| 53 | FTK | $722M | 24.2 | |
| 54 | JNJ | $542.4B | 25.8 | |
| 55 | VRTX | $113.6B | 26.2 | |
| 56 | TEVA | $41.1B | 26.3 | |
| 57 | SRPT | $1.9B | 29.0 | |
| 58 | APD | $62.0B | 29.4 | |
| 59 | LGND | $4.6B | 30.3 | |
| 60 | CHD | $22.7B | 30.9 | |
| 61 | SMG | $3.4B | 31.0 | |
| 62 | BCPC | $5.0B | 31.9 | |
| 63 | LIN | $230.1B | 32.5 | |
| 64 | MRK | $293.2B | 32.8 | |
| 65 | SXT | $4.8B | 33.6 | |
| 66 | WDFC | $2.7B | 33.6 | |
| 67 | ECL | $72.0B | 34.2 | |
| 68 | CL | $72.1B | 34.5 | |
| 69 | LLY | $985.4B | 39.0 | |
| 70 | KRYS | $9.1B | 40.5 | |
| 71 | IDXX | $44.5B | 40.6 | |
| 72 | BMRN | $11.1B | 41.2 | |
| 73 | SOLS | $13.4B | 56.4 | |
| 74 | HXL | $6.8B | 57.5 | |
| 75 | TECH | $8.1B | 73.9 | |
| 76 | LXFR | $460M | 79.3 | |
| 77 | VCEL | $1.7B | 79.3 | |
| 78 | ACNT | $122M | 103.8 | |
| 79 | ABBV | $384.7B | 105.8 | |
| 80 | ALNY | $40.3B | 128.5 | |
| 81 | RGEN | $7.0B | 136.0 | |
| 82 | CORT | $7.5B | 157.6 | |
| 83 | MOS | $7.6B | 168.8 | |
| 84 | ACB | $213M | 186.5 | |
| 85 | NNNN | $1.5B | 235.9 | |
| 86 | JAZZ | $14.8B | 503.1 |
How to turn this ranking into valuation work
Start with the company page
Validate business quality, margins, capital structure, and the current valuation context before relying on a single multiple.
Then validate WACC
A cheap multiple does not guarantee a sensible discount rate. Check cost of capital before finalizing DCF assumptions.
Finish with DCF
Use the matching DCF page to test intrinsic value so multiples, discount rates, and cash-flow assumptions stay connected.
P/E Ratio Rankings in Other Sectors
Data updated daily · Source: SEC EDGAR, Polygon.io